ANIX (Anixa Biosciences) Total Equity: $13.22 Mil (As of Apr. 2026)


ANIX Anixa Biosciences Inc ANIX
27 GF Score
Price $2.79
! 3 Warning Signs
View Full Analysis

What is Anixa Biosciences Total Equity?

Anixa Biosciences ANIX +5.88% 27 Total Equity is $13.22 Mil as of Apr. 2026. GuruFocus rates ANIX with a GF Score™ of 27/100. The stock has 3 warning signs investors should review.

Anixa Biosciences's total equity for the quarter that ended in Apr. 2026 was $13.22 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Anixa Biosciences Total Equity Historical Data

* Premium members only.

The historical data trend for Anixa Biosciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anixa Biosciences Total Equity Chart

Anixa Biosciences Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.77 28.20 23.37 18.89 13.95

Anixa Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.91 15.41 13.95 13.85 13.22
ANIX
27GF Score
Anixa Biosciences Inc ANIX
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anixa Biosciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Anixa Biosciences's Total Equity for the fiscal year that ended in Oct. 2025 is calculated as

Total Equity=Total Assets(Q: Oct. 2025 )-Total Liabilities(Q: Oct. 2025 )
=16.08-2.13
=13.95

Anixa Biosciences's Total Equity for the quarter that ended in Apr. 2026 is calculated as

Total Equity=Total Assets(Q: Apr. 2026 )-Total Liabilities(Q: Apr. 2026 )
=14.865-1.641
=13.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $13.22 Mil mean?
Anixa Biosciences (ANIX) has a Total Equity of $13.22 Mil as of Apr. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Anixa Biosciences and its competitors.
Is Anixa Biosciences' Total Equity too high?
Anixa Biosciences' current Total Equity is $13.22 Mil. Overall, Anixa Biosciences has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Anixa Biosciences' Total Equity compare to PYPD and LONA?
Anixa Biosciences' Total Equity of $13.22 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Anixa Biosciences and its competitors. Anixa Biosciences's current Total Equity is $13.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anixa Biosciences stock overvalued right now?
Anixa Biosciences (ANIX) has a current Total Equity of $13.22 Mil. The current Total Equity is $13.22 Mil. Anixa Biosciences' overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Anixa Biosciences (ANIX), the current Total Equity is $13.22 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anixa Biosciences Business Description

Other Exchanges CY71:Germany
Address 3150 Almaden Expressway, Suite 250, San Jose, CA, USA, 95118
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
27GF Score

Get the complete analysis for ANIX

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.79
Price